TH Open
(Jul 2022)
Emicizumab-induced photosensitivity
Pedro Asensi Cantó,
Mercedes Rodríguez Serna,
Pilar Lloret Madrid,
Jürgen Solís Ruiz,
Ana Rosa Cid Haro,
Santiago Bonanad Boix,
Saturnino Haya Guaita
Affiliations
Pedro Asensi Cantó
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
Mercedes Rodríguez Serna
Servicio de Dermatología, Hospital La Fe, Valencia, Spain.
Pilar Lloret Madrid
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
Jürgen Solís Ruiz
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
Ana Rosa Cid Haro
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
Santiago Bonanad Boix
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
Saturnino Haya Guaita
Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital La Fe, Valencia, Spain
DOI
https://doi.org/10.1055/s-0042-1749092
Journal volume & issue
Vol. 06,
no. 03
pp.
e154
– e155
Abstract
Read online
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present.
Keywords
Published in TH Open
ISSN
2512-9465 (Online)
Publisher
Georg Thieme Verlag KG
Country of publisher
Germany
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website
https://doi.org/10.1055/s-00033990
About the journal
WeChat QR code
Close